SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001640334-21-000086
Filing Date
2021-01-14
Accepted
2021-01-13 21:11:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 lxrp_424b4.htm 424B4 1573001
2 lxrp_10kimg45.jpg GRAPHIC 1592
3 lxrp_s1a1img46.jpg GRAPHIC 22529
  Complete submission text file 0001640334-21-000086.txt   1607589
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B4 | Act: 33 | File No.: 333-250326 | Film No.: 21527325
SIC: 2834 Pharmaceutical Preparations